Competitiveness

This section feature research, opinion and progress reports on how the Czech Republic compares to other EU countries economically. It includes analysis of international rankings such as the WEF and World Bank.

Show subcategories ▾

Spotlight issue

9th September 2020 / Competitiveness / Health Care

Pfizer and Biontech to potentially supply the EU with 200 million doses of mRNA-based vaccine candidate against SARS-CoV-2

 The proposed agreement is intended to provide a supply of 200 million doses and an option to purchase additional 100 million doses, with deliveries starting by the end of 2020, subject to regulatory approval  The vaccine supply for the EU would be produced by BioNTech’s manufacturing sites in Germany and Pfizer’s manufacturing site in Belgium  Pfizer and BioNTech are on track to seek regulatory review of BNT162b2 as early as October 2020 and, if regulatory authorization or approval is obtained, currently plan to supply up to 100 million doses worldwide by the end of 2020 and approximately 1.3 billion doses by the end of 2021

8th September 2020 / Competitiveness / Macroeconomic Indicators, Economic Growth

AmCham Board revises Economic impact assessment and recovery priorities

The next few months will tell the tale of how much impact Covid19 will have on the economy.

8th September 2020 / Competitiveness / Tax & Finance

Financial ecosystems to change banking, according to the Accenture survey

According to a survey conducted by Accenture, 88% of banks believe that ecosystems will change the bank-customer relationship in the future and that ecosystem-related initiatives will be the main driver of future value creation in the banking industry.